CD56+CD3- %

Optimal result: 5 – 27 %

CD56+CD3- % is a key immunological marker identifying natural killer (NK) cells, essential in innate immunity. Elevated levels can indicate an active immune response or certain malignancies, while decreased levels may suggest impaired immunity, as seen in HIV/AIDS or post-chemotherapy. This parameter is crucial in transplant immunology for monitoring immune reconstitution and in assessing the effectiveness of immunotherapies, particularly in cancer treatments. CD56+CD3- % thus plays a significant role in diagnosing, monitoring, and treating immune and hematological disorders.

CD56+CD3- % is a specialized immunological parameter, playing a pivotal role in the field of clinical immunology and hematology. This parameter specifically refers to the percentage of cells in the blood that express the CD56 marker but lack the CD3 marker. CD56 is a surface protein typically found on natural killer (NK) cells, a type of white blood cell crucial for the innate immune response, particularly in fighting viral infections and in cancer surveillance. The absence of the CD3 marker, typically present on T cells, helps in distinguishing these NK cells from other lymphocytes.

The CD56+CD3- % measurement is critical in diagnosing and monitoring various hematological disorders and immune deficiencies. For instance, an elevated percentage of CD56+CD3- cells can be indicative of an active immune response or certain hematological malignancies, such as NK cell leukemia. Conversely, a decreased percentage might suggest an impaired immune system, often seen in conditions like HIV/AIDS or following chemotherapy.

This parameter is also instrumental in the field of transplant immunology, particularly in monitoring the immune reconstitution after bone marrow or stem cell transplants. By evaluating the levels of CD56+CD3- NK cells, clinicians can assess the effectiveness of the transplant and the patient's ability to fight infections and potential relapse of the original disease.

Moreover, the CD56+CD3- % measurement is gaining increasing importance in the development and monitoring of new immunotherapies, especially in the treatment of cancers. These therapies often aim to enhance the activity of NK cells against cancer cells, making the monitoring of CD56+CD3- cells essential for evaluating treatment efficacy.

CD56+CD3- %
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond CD56+CD3- % — 10,000+ markers explained
One CD56+CD3- % result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro